Isolated tumor cells in stage I & II colon cancer patients are associated with significantly worse disease-free and overall survival
Conclusions:
This study provides compelling evidence that ITC in stage I & II colon cancer patients are associated with significantly worse disease-free and overall survival. Based on these data, the presence of ITC should be classified as a high risk factor in stage I & II colon cancer patients who might benefit from adjuvant chemotherapy.
Source: Epidemiologic Perspectives and Innovations - Category: Epidemiology Authors: B. WeixlerR. WarschkowU. GüllerA. ZettlU. von HolzenB. SchmiedM. Zuber Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Colon Cancer | Colorectal Cancer | Epidemiology | Study